Sorry, you need to enable JavaScript to visit this website.

Med school gets $1.5 million for ivermectin COVID trial

Med school gets $1.5 million for ivermectin COVID trial

An ongoing COVID-19 clinical trial studying the outpatient use of metformin, a generic medication for type 2 diabetes, has expanded ...

PLEASE LOG IN FOR PREMIUM CONTENT. Our website requires visitors to log in to view the best local news. Not yet a subscriber? Subscribe today!